Eli Lilly Corp. buy Barclays PLC
Start price
07.02.24
/
50%
€676.00
Target price
07.02.25
€751.76
Performance (%)
26.20%
End price
08.02.25
€853.10
Summary
This prediction ended on 08.02.25 with a price of €853.10. The prediction had a final performance of 26.20%. Dividends of €4.82 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | -0.835% | -0.835% | 17.100% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
Comments by Barclays_PLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Barclays PLC from $680.00 to $810.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barclays_PLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€771.40
31.10.24
31.10.24
€896.61
31.10.25
31.10.25
-3.29%
01.11.25
01.11.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€859.00
11.07.24
11.07.24
€941.16
11.07.25
11.07.25
-21.42%
12.07.25
12.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€580.50
23.01.24
23.01.24
€625.12
23.01.25
23.01.25
25.75%
24.01.25
24.01.25

